The Lancet Rheumatology
订阅
1. [Correspondence] Gout in central Asia: a few things make a big difference – Authors' reply Marita Cross, Kanyin Liane Ong, Hailey Hagins, Ewerton Cousin, Lyn March, Anthony Woolf
2. [Editorial] The 2024 US election—voting for equitable health care The Lancet Rheumatology
3. [News] Research in Brief Jennifer Thorley
4. [Correspondence] Gout in central Asia: a few things make a big difference Chokan Baimukhamedov, Galymzhan Togizbayev
5. [Corrections] Correction to Lancet Rheumatol 2024; 6: e664–65
6. [Comment] Explanation for substandard of care comparators in rheumatology randomised trial protocols Jacky Sheng, Andrew Zhang, Hannah Moyer, Marie Hudson, Glen Hazlewood, Vibeke Strand, Jonathan Kimmelman
7. [Correspondence] Inclusion of pregnant populations in clinical trials in China: the ethical considerations Xiaoyan Chen, Huifeng Shi, Barbara Wilkinson, Yuanfang Zhu
8. [Correspondence] Inclusive study design to better serve the needs of children and young people with rheumatological conditions Ameenat Lola Solebo, Salomey Kellett, UNICORNS Group
9. [Corrections] Correction to Lancet Rheumatol 2024; 6: e507–17
10. [Comment] Challenges and solutions for cellular therapy development in autoimmune diseases Elizabeth R Volkmann, John Varga, Bruce R Blazar, Steven Z Pavletic
11. [Comment] Treating antineutrophil cytoplasmic antibody-associated vasculitis in frail older adults Alexandra Legge
12. [Articles] The effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study Sebastian E Sattui, Bohang Jiang, Xiaoqing Fu, Claire Cook, Shruthi Srivatsan, Zachary K Williams, Guy Katz, Yuqing Zhang, Zachary S Wallace
13. [Comment] Uveitis relapse in Behçet's disease: a more nuanced approach is needed Jian-long Guan, Jun Zou
14. [Articles] Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial Zhenyu Zhong, Dan Deng, Yu Gao, Qingqing Bu, Lingyu Dai, Xiaojie Feng, Chong Tang, Xiang Luo, Yao Wang, Chunjiang Zhou, Guannan Su, Peizeng Yang
15. [Articles] Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials Ioannis Parodis, Julius Lindblom, Roger A Levy, Margherita Zen, Nursen Cetrez, Alvaro Gomez, Shereen Oon, Christine Henning, Munther Khamashta, Holly A Quasny, Deven Chauhan, Anca Askanase, Ronald van Vollenhoven, Mandana Nikpour
16. [Comment] Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab George Bertsias, Jinoos Yazdany
17. [Articles] Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort Karl Gisslander, Arthur White, Louis Aslett, Zdenka Hrušková, Peter Lamprecht, Jacek Musiał, Jamsheela Nazeer, James Ng, Declan O'Sullivan, Xavier Puéchal, Matthew Rutherford, Mårten Segelmark, Benjamin Terrier, Vladimir Tesař, Michelangelo Tesi, Augusto Vaglio, Krzysztof Wójcik, Mark A Little, Aladdin J Mohammad, FAIRVASC consortium
18. [Comment] Reclassifying ANCA-associated vasculitis: a focus on kidney disease Ilay Berke, Andreas Kronbichler
19. [Review] Calcium pyrophosphate deposition disease Tristan Pascart, Georgios Filippou, Frédéric Lioté, Silvia Sirotti, Charlotte Jauffret, Abhishek Abhishek
20. [Viewpoint] Arthritis complicating inflammatory bowel disease— the future is now Kaiyang Song, Jack Satsangi, Laura C Coates
更新于 47 分钟前

近期历史最近 100 条记录

2024-10-22 [Correspondence] Gout in central Asia: a few things make a big difference – Authors' reply Marita Cross, Kanyin Liane Ong, Hailey Hagins, Ewerton Cousin, Lyn March, Anthony Woolf
2024-10-22 [Editorial] The 2024 US election—voting for equitable health care The Lancet Rheumatology
2024-10-22 [News] Research in Brief Jennifer Thorley
2024-10-22 [Correspondence] Gout in central Asia: a few things make a big difference Chokan Baimukhamedov, Galymzhan Togizbayev
2024-10-22 [Corrections] Correction to Lancet Rheumatol 2024; 6: e664–65
2024-10-22 [Comment] Explanation for substandard of care comparators in rheumatology randomised trial protocols Jacky Sheng, Andrew Zhang, Hannah Moyer, Marie Hudson, Glen Hazlewood, Vibeke Strand, Jonathan Kimmelman
2024-10-22 [Correspondence] Inclusion of pregnant populations in clinical trials in China: the ethical considerations Xiaoyan Chen, Huifeng Shi, Barbara Wilkinson, Yuanfang Zhu
2024-10-22 [Correspondence] Inclusive study design to better serve the needs of children and young people with rheumatological conditions Ameenat Lola Solebo, Salomey Kellett, UNICORNS Group
2024-10-22 [Corrections] Correction to Lancet Rheumatol 2024; 6: e507–17
2024-10-22 [Comment] Challenges and solutions for cellular therapy development in autoimmune diseases Elizabeth R Volkmann, John Varga, Bruce R Blazar, Steven Z Pavletic
2024-10-22 [Comment] Treating antineutrophil cytoplasmic antibody-associated vasculitis in frail older adults Alexandra Legge
2024-10-22 [Articles] The effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study Sebastian E Sattui, Bohang Jiang, Xiaoqing Fu, Claire Cook, Shruthi Srivatsan, Zachary K Williams, Guy Katz, Yuqing Zhang, Zachary S Wallace
2024-10-22 [Articles] Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial Zhenyu Zhong, Dan Deng, Yu Gao, Qingqing Bu, Lingyu Dai, Xiaojie Feng, Chong Tang, Xiang Luo, Yao Wang, Chunjiang Zhou, Guannan Su, Peizeng Yang
2024-10-22 [Comment] Uveitis relapse in Behçet's disease: a more nuanced approach is needed Jian-long Guan, Jun Zou
2024-10-22 [Articles] Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials Ioannis Parodis, Julius Lindblom, Roger A Levy, Margherita Zen, Nursen Cetrez, Alvaro Gomez, Shereen Oon, Christine Henning, Munther Khamashta, Holly A Quasny, Deven Chauhan, Anca Askanase, Ronald van Vollenhoven, Mandana Nikpour
2024-10-22 [Comment] Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab George Bertsias, Jinoos Yazdany
2024-10-22 [Articles] Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort Karl Gisslander, Arthur White, Louis Aslett, Zdenka Hrušková, Peter Lamprecht, Jacek Musiał, Jamsheela Nazeer, James Ng, Declan O'Sullivan, Xavier Puéchal, Matthew Rutherford, Mårten Segelmark, Benjamin Terrier, Vladimir Tesař, Michelangelo Tesi, Augusto
2024-10-22 [Comment] Reclassifying ANCA-associated vasculitis: a focus on kidney disease Ilay Berke, Andreas Kronbichler
2024-10-22 [Review] Calcium pyrophosphate deposition disease Tristan Pascart, Georgios Filippou, Frédéric Lioté, Silvia Sirotti, Charlotte Jauffret, Abhishek Abhishek
2024-10-22 [Viewpoint] Arthritis complicating inflammatory bowel disease— the future is now Kaiyang Song, Jack Satsangi, Laura C Coates
2024-09-24 [Editorial] Trials and tribulations for children with rheumatic diseases The Lancet Rheumatology
2024-09-24 [News] Research in Brief Jennifer Thorley
2024-09-24 [Correspondence] Clinical hypnosis and pain management in sharp debridement of skin ulcers in immune-mediated inflammatory diseases Begonya Alcacer-Pitarch, Francesco Del Galdo, Helena Marzo-Ortega
2024-09-24 [Articles] The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study Gabrielle Virgili-Gervais, Bianca Matthews, Elsa-Lynn Nassar, Marie-Eve Carrier, Linda Kwakkenbos, John D Pauling, Susan J Bartlett, Amy Gietzen, Karen Gottesman, Geneviève Guillot, Marie Hudson, Laura K Hummers, Amanda Lawrie-Jones, Vanessa L Malcarne, M
2024-09-24 [Comment] Outdoor temperatures and Raynaud's phenomenon in patients with systemic sclerosis Maurizio Cutolo, Vanessa Smith, Elvis Hysa
2024-09-24 [Articles] Identification and evolution of predictors of Sjögren's disease-associated mucosa-associated lymphoid tissue lymphoma development over time: a case-control study Andreas V Goules, Loukas Chatzis, Vasilis C Pezoulas, Markos Patsouras, Clio Mavragani, Luca Quartuccio, Chiara Baldini, Salvatore De Vita, Dimitrios I Fotiadis, Athanasios G Tzioufas
2024-09-24 [Articles] Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study Juliette Rocca, Maxime Beydon, Véronique Le Guern, Eric Hachulla, Marion Couderc, Sandrine Jousse-Joulin, Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Olivier Vittecoq, Christian Lavigne, Jean Schmidt, Claire Larroche, Xavier Mariette, Raphaèle Se
2024-09-24 [Comment] A future for prediction and treatment of Sjögren's disease-associated lymphomas Suzanne Arends, Arjan Vissink, Frans G M Kroese, Gwenny M Verstappen, Hendrika Bootsma
2024-09-24 [Comment] Pregnancy outcome predictors in systemic lupus erythematosus: prospective for brighter perspectives Grégoire Martin de Frémont, Jane E Salmon, Nathalie Costedoat-Chalumeau
2024-09-24 [Articles] Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis Merlijn Wind, Juan J Fierro, Kitty W M Bloemenkamp, Karina de Leeuw, A Titia Lely, Maarten Limper, Marieke Sueters, Y K Onno Teng, Isabel J Walter, Judith Kooiman
2024-09-24 [Review] Systemic lupus erythematosus in Aboriginal and Torres Strait Islander peoples in Australia: addressing disparities and barriers to optimising patient care Laura E Eades, Alberta Y Hoi, Ruaidhri Liddle, Jason Sines, Rangi Kandane-Rathnayake, Sachin Khetan, Johannes Nossent, Greta Lindenmayer, Eric F Morand, David F L Liew, Maureen Rischmueller, Stephen Brady, Alex Brown, Fabien B Vincent
2024-09-24 [Comment] Experiences of telehealth during and after the COVID-19 pandemic and preferences for future care of people with systemic sclerosis: a cross-sectional study Elsa-Lynn Nassar, Gabrielle Virgili-Gervais, Marie-Eve Carrier, Linda Kwakkenbos, Richard S Henry, Sophie Hu, Sabrina Provencher, Meira Golberg, Susan J Bartlett, Luc Mouthon, Scott B Patten, John Varga, Andrea Benedetti, Brett D Thombs, Scleroderma Patie
2024-09-24 [Viewpoint] Clinical assessment and management of lumbar spinal stenosis: clinical dilemmas and considerations for surgical referral David B Anderson, David J Beard, Francois Rannou, David J Hunter, Pradeep Suri, Lingxiao Chen, James M Van Gelder
2024-08-20 [Editorial] Advancing research and equity through collaboration The Lancet Rheumatology
2024-08-20 [News] Research in Brief Jennifer Thorley
2024-08-20 [Articles] Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study Melanie Nana, Maria Gregori, Eleanor Chandler, Hazel Powell, Bethan Goulden, Timothy Watts, Mandish K Dhanjal, Catherine Nelson-Piercy
2024-08-20 [Comment] Interleukin-6 receptor antagonists in pregnancy: a reason for cautious optimism Steven L Clark
2024-08-20 [Comment] Advancing predictive accuracy for shoulder replacement surgery Erica Kholinne, Jae-Man Kwak
2024-08-20 [Articles] Risk of serious adverse events after primary shoulder replacement: development and external validation of a prediction model using linked national data from England and Denmark Epaminondas Markos Valsamis, Marie Louise Jensen, Gillian Coward, Adrian Sayers, Rafael Pinedo-Villanueva, Jeppe V Rasmussen, Gary S Collins, Jonathan L Rees
2024-08-20 [Articles] Effectiveness of pneumococcal vaccination in adults with common immune-mediated inflammatory diseases in the UK: a case–control study Georgina Nakafero, Matthew J Grainge, Tim Card, Christian D Mallen, Jonathan S Nguyen Van-Tam, Abhishek Abhishek
2024-08-20 [Comment] Pneumococcal vaccine in adults with immune-mediated inflammatory diseases Meliha C Kapetanovic
2024-08-20 [Comment] Towards improving the Global Burden of Disease estimates for low back pain Mark Hancock, Alice Kongsted
2024-08-20 [Articles] Assessing the impact of health-care access on the severity of low back pain by country: a case study within the GBD framework YiFan Wu, Sarah Wulf Hanson, Garland Culbreth, Caroline Purcell, Peter Brooks, Jacek Kopec, Lyn March, Anthony D Woolf, Maja Pasovic, Erin Hamilton, Damian Santomauro, Theo Vos
2024-08-20 [Insights] Fighting to be heard—a painful journey of misdiagnoses Luc J Beck, Katherine I Wolf
2024-08-20 [Comment] Engagement of people with lived experience in studies published in high-impact rheumatology journals: a meta-research review Claire Adams, Elsa-Lynn Nassar, Julia Nordlund, Cassidy Dal Santo, Danielle B Rice, Vanessa Cook, Jill T Boruff, Brett D Thombs
2024-08-20 [Review] Precision medicine in Sjögren's disease Saviana Gandolfo, Michele Bombardieri, Jacques-Olivier Pers, Xavier Mariette, Francesco Ciccia
2024-08-20 [Viewpoint] How can trial designs better serve the needs of children and young people with juvenile idiopathic arthritis? Freya Luling Feilding, Laura Crosby, Emily Earle, Richard Beesley, Kerry Leslie, Eilean MacDonald, Catherine Wright, Debbie Wilson, Anna Sherriffs, Teresa Duerr, Athimalaipet V Ramanan, CLUSTER Consortium
2024-07-23 [Corrections] Correction to Lancet Rheumatol 2024; 6: e537–45
2024-07-23 [Editorial] Navigating the complexities of pregnancy in rheumatic disease The Lancet Rheumatology
2024-07-23 [News] Research in Brief Jennifer Thorley
2024-07-23 [Comment] Gout prevalence is rising in low-income and middle-income countries: are we ready? Kanon Jatuworapruk
2024-07-23 [Articles] Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 GBD 2021 Gout Collaborators
2024-07-23 [Corrections] Correction to Lancet Rheumatol 2023; 5: e130–38
2024-07-23 [Articles] Annual trends in pain management modalities in patients with newly diagnosed autoimmune rheumatic diseases in the USA from 2007 to 2021: an administrative claims-based study Titilola Falasinnu, Di Lu, Matthew C Baker
2024-07-23 [Comment] Trends in opioid use for autoimmune rheumatic diseases Erika P Navarro-Mendoza, Alí Duarte-García
2024-07-23 [Articles] Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial Claudia Worth, M Hussein Al-Mossawi, Joanne Macdonald, Benjamin A Fisher, Antoni Chan, Raj Sengupta, Jonathan Packham, Karl Gaffney, Nicola Gullick, Jonathan A Cook, Tim H Corn, James Teh, Pedro M Machado, Peter C Taylor, Paul Bowness
2024-07-23 [Comment] Proof-of-concept studies in axial spondyloarthritis: there are no shortcuts Walter P Maksymowych
2024-07-23 [Correspondence] Optimal non-opioid analgesic combinations after total hip arthroplasty Fu-Shan Xue, Dao-Yi Lin, Xiao-Chun Zheng
2024-07-23 [Correspondence] Optimal non-opioid analgesic combinations after total hip arthroplasty – Authors' reply Joakim Steiness, Troels Haxholdt Lunn, Daniel Hägi-Pedersen, Janus Christian Jakobsen, Ole Mathiesen
2024-07-23 [Articles] Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study Vera Golder, Rangi Kandane-Rathnayake, Ning Li, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue Fen Luo, Yeong-Jian Wu, Sandra V Navarra, Leonid Zamora, Zhanguo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi H
2024-07-23 [Comment] Research, pregnancy, and the ethics of parental consent Anne Drapkin Lyerly
2024-07-23 [Insights] Silvia Aguilera: learning from lived experience Udani Samarasekera
2024-07-23 [Series] The outcomes of children born to mothers with autoimmune rheumatic diseases Laura Andreoli, Jeanette Andersen, Tadej Avcin, Christina D Chambers, Elisa M Fazzi, Neil Marlow, Nico M Wulffraat, Angela Tincani
2024-07-23 [Series] The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy management Ian Giles, Iona Thorne, Nanna Surlemont Schmidt, Claire Reid, Amy Crossley, Monica Panca, Nick Freemantle, Clare Tower, Shouvik Dass, Shefali K Sharma, David Williams, Sean O'Neill, Radboud J E M Dolhain, Nataša Toplak, Kenneth Hodson, Catherine Nelson-Pi
2024-07-23 [Series] Challenges of designing and conducting cohort studies and clinical trials in populations of pregnant people Karen Schreiber, Christine Graversgaard, Beverley J Hunt, James M S Wason, Nathalie Costedoat-Chalumeau, Silvia Aguilera, Marta M Guerra, Jane E Salmon
2024-07-23 [Comment] For SLE activity and glucocorticoids: aim low Martin Aringer, Jinoos Yazdany
2024-06-18 [News] Research in Brief Jennifer Thorley
2024-06-18 [Correspondence] Contesting the BACPAP consortium's consensus Milton Cohen, Asaf Weisman, John Quintner
2024-06-18 [Correspondence] Contesting the BACPAP consortium's consensus – Authors' reply Eva Kosek, Jo Nijs, Alessandro Chiarotto, Chad Cook, Lieven A Danneels, César Fernández-de-las-Peñas, Paul W Hodges, Bart Koes, Adriaan Louw, Raymond Ostelo, Gwendolyne G M Scholten-Peeters, Michele Sterling, Othman Alkassabi, Hana Alsobayel, Darren Beale
2024-06-18 [Editorial] Digital self-management for back pain in the UK The Lancet Rheumatology
2024-06-18 [Articles] Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries Eleana Bolla, Anne Grete Semb, Anne M Kerola, Eirik Ikdahl, Michelle Petri, Guillermo J Pons-Estel, George A Karpouzas, Petros P Sfikakis, Rosana Quintana, Durga Prasanna Misra, Eduardo Ferreira Borba, Ignacio Garcia-de la Torre, Tatiana V Popkova, Bahar
2024-06-18 [Comment] Systemic lupus erythematosus: managing cardiovascular risk factors Anisur Rahman
2024-06-18 [Articles] Outcomes after anti-tumour necrosis factor originator to biosimilar switching in children and young people with juvenile idiopathic arthritis in the UK: a national cohort study Lianne Kearsley-Fleet, Eileen Baildam, Michael W Beresford, Sharon Douglas, Helen E Foster, Taunton R Southwood, Kimme L Hyrich, UK JIA Biologics Register
2024-06-18 [Comment] Biosimilars in childhood chronic rheumatic diseases: friend or foe? Ilaria Maccora, Gabriele Simonini
2024-06-18 [Articles] Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology–European League Against Rheumatism classification criteria Isha Jha, Grace A McMahon, Cory A Perugino, Guy Katz, Zachary S Wallace, Ana Fernandes, Bohang Jiang, Yuqing Zhang, Aubree E McMahon, Thomas V Guy, Hang Liu, Yasmin G Hernandez-Barco, Shiv Pillai, John H Stone
2024-06-18 [Articles] Supporting self-management of low back pain with an internet intervention with and without telephone support in primary care (SupportBack 2): a randomised controlled trial of clinical and cost-effectiveness Adam W A Geraghty, Taeko Becque, Lisa C Roberts, Jonathan C Hill, Nadine E Foster, Lucy Yardley, Beth Stuart, David A Turner, Elaine Hay, Gareth Griffiths, Frances Webley, Lorraine Durcan, Alannah Morgan, Stephanie Hughes, Sarah Bathers, Stephanie Butler-
2024-06-18 [Comment] Welcome new evidence on self-management of back pain Chris Maher, Chung-Wei Christine Lin
2024-06-18 [Comment] Sex bias in IgG4-related disease: from clinical phenotype to mechanisms Jiaxin Zhou, Wen Zhang
2024-06-18 [Insights] Stop ticking boxes: it just doesn't work Jules Morgan
2024-06-18 [Series] Fibrotic phenotype of IgG4-related disease Marco Lanzillotta, Emma Culver, Amita Sharma, Yoh Zen, Wen Zhang, John H Stone, Emanuel Della-Torre
2024-06-18 [Series] Proliferative features of IgG4-related disease Guy Katz, Yasmin Hernandez-Barco, Diego Palumbo, Thomas V Guy, Lingli Dong, Cory A Perugino
2024-05-22 [Articles] Identifying key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases: a mixed-methods study Rosemary J Hollick, Warren R G James, Avril Nicoll, Louise Locock, Corri Black, Neeraj Dhaun, Allyson C Egan, Nicholas Fluck, Lynn Laidlaw, Peter C Lanyon, Mark A Little, Raashid Ahmed Luqmani, Laura Moir, Maureen McBain, Neil Basu
2024-05-22 [News] Research in Brief Jennifer Thorley
2024-05-22 [Editorial] Time to listen to women about their pain The Lancet Rheumatology
2024-05-22 [Articles] Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study Gonzalo Borrego-Yaniz, Lourdes Ortiz-Fernández, Adela Madrid-Paredes, Martin Kerick, José Hernández-Rodríguez, Sarah L Mackie, Augusto Vaglio, Santos Castañeda, Roser Solans, Jaume Mestre-Torres, Nader Khalidi, Carol A Langford, Steven Ytterberg, Lorenzo
2024-05-22 [Articles] Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial Carl S Goodyear, Amit Patel, Eleanor Barnes, Michelle Willicombe, Stefan Siebert, Thushan I de Silva, John A Snowden, Sean H Lim, Sarah J Bowden, Lucinda Billingham, Alex Richter, Miles Carroll, Edward J Carr, Rupert Beale, Daniel Rea, Helen Parry, Sarah
2024-05-22 [Comment] Giant cell arteritis: when genomics drives precision medicine Davide Martorana, Ingeborg M Bajema
2024-05-22 [Comment] Additional SARS-CoV-2 vaccine doses: a little is better than none Alfred H J Kim
2024-05-22 [Articles] Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial Jin Kyun Park, Miriam Kim, Ji In Jung, Ju Yeon Kim, Heejin Jeong, Jun Won Park, Kevin L Winthrop, Eun Bong Lee
2024-05-22 [Comment] Protecting patients with SLE against herpes zoster: time for early proactive vaccine counselling Laura Boekel
2024-05-22 [Corrections] Correction to Lancet Rheumatol 2022; 4: e177–87
2024-05-22 [News] CAR T-cell therapy for SLE in children Talha Burki
2024-05-22 [Series] Large vessel giant cell arteritis Kornelis S M van der Geest, Maria Sandovici, Thorsten A Bley, James R Stone, Riemer H J A Slart, Elisabeth Brouwer
2024-05-22 [Series] Cranial involvement in giant cell arteritis Philipp Bosch, Georgina Espigol-Frigolé, Maria C Cid, Susan P Mollan, Wolfgang A Schmidt
2024-05-22 [Clinical Picture] ANCA-associated large and small vessel vasculitis with aorto-pulmonary-renal syndrome Tajamul H Mir, Parvaiz A Zargar, Bushra Jabeen, Muzamil Latief, Alok Sharma, Nisar A Wani, Syed Mubashir Nissar, Aabid Hussain, Abid Kuchay, Abdul Rasheed Ahangar, Murtaza Rashid Pala, M Omar Parvaiz
2024-04-23 [Articles] The Florida Scoring System for stratifying children with suspected Sjögren's disease: a cross-sectional machine learning study Wenjie Zeng, Akaluck Thatayatikom, Nicole Winn, Tyler C Lovelace, Indraneel Bhattacharyya, Thomas Schrepfer, Ankit Shah, Renato Gonik, Panayiotis V Benos, Seunghee Cha
2024-04-23 [Insight] Debashish Danda Sakir Ahmed
2024-04-23 [Comment] Cardiovascular risk in young people with childhood onset systemic lupus erythematosus Coziana Ciurtin, George Robinson, Maryam Butt, Junjie Peng, Stacy Ardoin, Laura Schanberg, Alina Boteanu, Katerina Bouchalova, Selcan Demir, Elena Moraitis, Angela Migowa, Yvonne Glackin, Jenny Ainsworth, Eve Smith, Elizabeth Jury, Sezgin Sahin, Sylvia Ka
2024-04-23 [News] Research in Brief Jennifer Thorley
2024-04-23 [Comment] A new tool for stratifying children with suspected Sjögren's disease Coziana Ciurtin, Elizabeth C Jury

匿名用户只展示最新 100 条榜单历史,更多历史数据请登录后查看,支持时光机按天筛选